Among these factors, SRSF2 and SF3B1 are prominently associated with leukemia, as detailed in Table 1; previous studies have linked mutations in these splicing factors to adverse prognoses, primarily through alteration of the RNA splicing mechanism [18–21]. This evidence concerns the gene SF3B1 and leukemia.